Merdad Parsey - 10 Jun 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Medical Officer
Signature: /s/ Edward S. Son by Power of Attorney for Merdad Parsey
Issuer symbol: GILD
Transactions as of: 10 Jun 2023
Net transactions value: -$101,087
Form type: 4
Filing time: 12 Jun 2023, 16:45:50 UTC
Previous filing: 14 Mar 2023
Next filing: 14 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+2,779	+9.5%		32,181	10 Jun 2023	Direct	F1
transaction	GILD	Common Stock	Tax liability	$101,087	-1,294	-4%	$78.12	30,887	10 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-2,779	-5.6%		46,533	10 Jun 2023	Common Stock	2,779		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.